Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of sequestering of triglyceride (GO:0010889) | 6.99496617 |
2 | low-density lipoprotein particle clearance (GO:0034383) | 6.78686627 |
3 | fatty acid transmembrane transport (GO:1902001) | 5.83165581 |
4 | fatty acid beta-oxidation (GO:0006635) | 5.53693520 |
5 | carnitine shuttle (GO:0006853) | 5.52483033 |
6 | triglyceride catabolic process (GO:0019433) | 5.44754611 |
7 | biotin metabolic process (GO:0006768) | 5.41222768 |
8 | valine metabolic process (GO:0006573) | 5.36067540 |
9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.29353495 |
10 | positive regulation of fatty acid oxidation (GO:0046321) | 5.28707656 |
11 | neutral lipid catabolic process (GO:0046461) | 5.06758006 |
12 | acylglycerol catabolic process (GO:0046464) | 5.06758006 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.99647920 |
14 | fatty acid oxidation (GO:0019395) | 4.98441084 |
15 | regulation of cholesterol storage (GO:0010885) | 4.97932293 |
16 | brown fat cell differentiation (GO:0050873) | 4.96060856 |
17 | lipid oxidation (GO:0034440) | 4.90035639 |
18 | fatty acid catabolic process (GO:0009062) | 4.85420181 |
19 | regulation of fatty acid oxidation (GO:0046320) | 4.80175870 |
20 | regulation of triglyceride catabolic process (GO:0010896) | 4.61211052 |
21 | acetyl-CoA metabolic process (GO:0006084) | 4.53597823 |
22 | plasma lipoprotein particle clearance (GO:0034381) | 4.51811278 |
23 | carnitine transmembrane transport (GO:1902603) | 4.46413646 |
24 | branched-chain amino acid catabolic process (GO:0009083) | 4.33205772 |
25 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.30676512 |
26 | positive regulation of lipid catabolic process (GO:0050996) | 4.29155415 |
27 | complement activation, alternative pathway (GO:0006957) | 4.25807807 |
28 | white fat cell differentiation (GO:0050872) | 4.25444501 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25278344 |
30 | branched-chain amino acid metabolic process (GO:0009081) | 4.20581960 |
31 | amino-acid betaine transport (GO:0015838) | 4.20386707 |
32 | carnitine transport (GO:0015879) | 4.20386707 |
33 | monocarboxylic acid catabolic process (GO:0072329) | 4.13003237 |
34 | tricarboxylic acid cycle (GO:0006099) | 4.11571868 |
35 | sulfur amino acid catabolic process (GO:0000098) | 4.05350447 |
36 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.04389588 |
37 | positive regulation of lipid storage (GO:0010884) | 4.03038175 |
38 | lysine metabolic process (GO:0006553) | 4.02385835 |
39 | lysine catabolic process (GO:0006554) | 4.02385835 |
40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.01391536 |
41 | carnitine metabolic process (GO:0009437) | 3.89642874 |
42 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88859094 |
43 | triglyceride biosynthetic process (GO:0019432) | 3.87942145 |
44 | short-chain fatty acid metabolic process (GO:0046459) | 3.86708360 |
45 | lipid particle organization (GO:0034389) | 3.86314554 |
46 | tricarboxylic acid metabolic process (GO:0072350) | 3.86179539 |
47 | NADH metabolic process (GO:0006734) | 3.84883071 |
48 | thioester biosynthetic process (GO:0035384) | 3.84357994 |
49 | acyl-CoA biosynthetic process (GO:0071616) | 3.84357994 |
50 | triglyceride homeostasis (GO:0070328) | 3.84221421 |
51 | acylglycerol homeostasis (GO:0055090) | 3.84221421 |
52 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.84109652 |
53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.82263492 |
54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.78875456 |
55 | L-phenylalanine catabolic process (GO:0006559) | 3.78875456 |
56 | neutral lipid biosynthetic process (GO:0046460) | 3.78338091 |
57 | acylglycerol biosynthetic process (GO:0046463) | 3.78338091 |
58 | amino-acid betaine metabolic process (GO:0006577) | 3.76859177 |
59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71292003 |
60 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71292003 |
61 | L-phenylalanine metabolic process (GO:0006558) | 3.66305770 |
62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.66305770 |
63 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.65618149 |
64 | triglyceride metabolic process (GO:0006641) | 3.64657111 |
65 | lipid storage (GO:0019915) | 3.63811467 |
66 | glycerolipid catabolic process (GO:0046503) | 3.63337804 |
67 | intracellular lipid transport (GO:0032365) | 3.60795402 |
68 | barbed-end actin filament capping (GO:0051016) | 3.58967759 |
69 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.58910446 |
70 | succinate metabolic process (GO:0006105) | 3.54084596 |
71 | regulation of triglyceride metabolic process (GO:0090207) | 3.53742119 |
72 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.48228860 |
73 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.46950082 |
74 | polyketide metabolic process (GO:0030638) | 3.46533957 |
75 | doxorubicin metabolic process (GO:0044598) | 3.46533957 |
76 | daunorubicin metabolic process (GO:0044597) | 3.46533957 |
77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.45368330 |
78 | acylglycerol metabolic process (GO:0006639) | 3.44447908 |
79 | fatty acid homeostasis (GO:0055089) | 3.40784881 |
80 | neutral lipid metabolic process (GO:0006638) | 3.38759396 |
81 | quaternary ammonium group transport (GO:0015697) | 3.38392522 |
82 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.38051436 |
83 | epoxygenase P450 pathway (GO:0019373) | 3.36222942 |
84 | glycosphingolipid catabolic process (GO:0046479) | 3.31691008 |
85 | urea metabolic process (GO:0019627) | 3.31130157 |
86 | urea cycle (GO:0000050) | 3.31130157 |
87 | cellular ketone body metabolic process (GO:0046950) | 3.28017247 |
88 | adhesion of symbiont to host (GO:0044406) | 3.27829369 |
89 | negative regulation of lipase activity (GO:0060192) | 3.27778408 |
90 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.27474279 |
91 | oxaloacetate metabolic process (GO:0006107) | 3.27020434 |
92 | negative regulation of lipid storage (GO:0010888) | 3.23447784 |
93 | acyl-CoA metabolic process (GO:0006637) | 3.23301635 |
94 | thioester metabolic process (GO:0035383) | 3.23301635 |
95 | regulation of lipid catabolic process (GO:0050994) | 3.18824951 |
96 | regulation of cholesterol metabolic process (GO:0090181) | 3.18750064 |
97 | regulation of lipid storage (GO:0010883) | 3.17276031 |
98 | coenzyme A biosynthetic process (GO:0015937) | 3.16797769 |
99 | carboxylic acid catabolic process (GO:0046395) | 3.16107645 |
100 | organic acid catabolic process (GO:0016054) | 3.16107645 |
101 | phospholipid homeostasis (GO:0055091) | 3.15625758 |
102 | ethanol oxidation (GO:0006069) | 3.15411828 |
103 | apoptotic cell clearance (GO:0043277) | 3.15075701 |
104 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.14317923 |
105 | cysteine metabolic process (GO:0006534) | 3.13731268 |
106 | nitrogen cycle metabolic process (GO:0071941) | 3.12800760 |
107 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.11923368 |
108 | transcytosis (GO:0045056) | 3.11559649 |
109 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.09539022 |
110 | regulation of protein activation cascade (GO:2000257) | 3.09137764 |
111 | glyoxylate metabolic process (GO:0046487) | 3.06139995 |
112 | cellular lipid catabolic process (GO:0044242) | 3.06117730 |
113 | regulation of complement activation (GO:0030449) | 3.05171673 |
114 | oligosaccharide catabolic process (GO:0009313) | 3.04165093 |
115 | adhesion of symbiont to host cell (GO:0044650) | 3.03490174 |
116 | virion attachment to host cell (GO:0019062) | 3.03490174 |
117 | glycolipid catabolic process (GO:0019377) | 2.99165178 |
118 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.96105619 |
119 | regulation of vitamin metabolic process (GO:0030656) | 2.94959678 |
120 | regulation of mononuclear cell migration (GO:0071675) | 2.94694935 |
121 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.94661000 |
122 | serine transport (GO:0032329) | 2.91254052 |
123 | positive regulation of extracellular matrix organization (GO:1903055) | 2.91115925 |
124 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88491395 |
125 | diacylglycerol metabolic process (GO:0046339) | 2.83762264 |
126 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.81417560 |
127 | cellular response to arsenic-containing substance (GO:0071243) | 2.81267223 |
128 | positive regulation of cholesterol efflux (GO:0010875) | 2.78227091 |
129 | regulation of cholesterol homeostasis (GO:2000188) | 2.75840767 |
130 | keratan sulfate catabolic process (GO:0042340) | 2.70661563 |
131 | negative regulation of macrophage differentiation (GO:0045650) | 2.68474849 |
132 | protein localization to endosome (GO:0036010) | 2.67386554 |
133 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65811056 |
134 | cellular response to cadmium ion (GO:0071276) | 2.64558919 |
135 | NIK/NF-kappaB signaling (GO:0038061) | 2.63920703 |
136 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.61929662 |
137 | glycoside metabolic process (GO:0016137) | 2.57752888 |
138 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57418010 |
139 | response to thyroid hormone (GO:0097066) | 2.55467732 |
140 | skin morphogenesis (GO:0043589) | 2.54671668 |
141 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.52908089 |
142 | protein carboxylation (GO:0018214) | 2.52908089 |
143 | ovulation from ovarian follicle (GO:0001542) | 2.52631395 |
144 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.52059620 |
145 | pentose-phosphate shunt (GO:0006098) | 2.51704836 |
146 | ceramide catabolic process (GO:0046514) | 2.51249814 |
147 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50935013 |
148 | regulation of gonadotropin secretion (GO:0032276) | 2.50781371 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.49356081 |
150 | regulation of superoxide anion generation (GO:0032928) | 2.48771587 |
151 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.47718016 |
152 | diaphragm development (GO:0060539) | 2.46422423 |
153 | COPI coating of Golgi vesicle (GO:0048205) | 2.44267965 |
154 | Golgi transport vesicle coating (GO:0048200) | 2.44267965 |
155 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.43309995 |
156 | regulation of macrophage chemotaxis (GO:0010758) | 2.42939687 |
157 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42098411 |
158 | cellular response to zinc ion (GO:0071294) | 2.39945700 |
159 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.39321755 |
160 | protein heterotrimerization (GO:0070208) | 2.38746105 |
161 | pinocytosis (GO:0006907) | 2.36086291 |
162 | stress fiber assembly (GO:0043149) | 2.35288250 |
163 | myeloid dendritic cell differentiation (GO:0043011) | 2.34282298 |
164 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.34221128 |
165 | hyaluronan catabolic process (GO:0030214) | 2.33353966 |
166 | regulation of superoxide metabolic process (GO:0090322) | 2.33280173 |
167 | membrane lipid catabolic process (GO:0046466) | 2.33209633 |
168 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.32962942 |
169 | negative regulation of metanephros development (GO:0072217) | 2.32108259 |
170 | primary alcohol catabolic process (GO:0034310) | 2.32013986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.19484775 |
2 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.41378724 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.38241943 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.74468474 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43919571 |
6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.83155604 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55739838 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.08902681 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.86286166 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.71161741 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.60186008 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50758974 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31531019 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 11.8688859 |
15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86907575 |
16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76731457 |
17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.76696969 |
18 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.73253664 |
19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72134013 |
20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63305461 |
21 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62567046 |
22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.57456951 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53342071 |
24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53210051 |
25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50854016 |
26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47345061 |
27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45917042 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45379033 |
29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44609603 |
30 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.43592932 |
31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43407104 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43338947 |
33 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.38711137 |
34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36172890 |
35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32848782 |
36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32692221 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32632766 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32035158 |
39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31594344 |
40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29752862 |
41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28398837 |
42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26879072 |
43 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24509968 |
44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21396782 |
45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.20906565 |
46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18937522 |
47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18851868 |
48 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17505418 |
49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17451493 |
50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15735869 |
51 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13821866 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12269219 |
53 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11517141 |
54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11517141 |
55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10968361 |
56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10303008 |
57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10303008 |
58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10224286 |
59 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09123785 |
60 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08265919 |
61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06955136 |
62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06945796 |
63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06505315 |
64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06134010 |
65 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04410447 |
66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04302706 |
67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03636242 |
68 | P68_20966046_ChIP-Seq_HELA_Human | 1.03014674 |
69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01872256 |
70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01526719 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01314322 |
72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00351212 |
73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99503858 |
74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99115394 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98312975 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97527103 |
77 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97222942 |
78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96598562 |
79 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96487228 |
80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96353028 |
81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96125541 |
82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95468650 |
83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94735136 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94662747 |
85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94471348 |
86 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.92195551 |
87 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92167504 |
88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91806232 |
89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91323077 |
90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90907618 |
91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89277108 |
92 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88392819 |
93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87562559 |
94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87562559 |
95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86850801 |
96 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86766706 |
97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85841898 |
98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84407651 |
99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83062052 |
100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82357217 |
101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82345047 |
102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82079690 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81537610 |
104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81267382 |
105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81224668 |
106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80570068 |
107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78701581 |
108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78582052 |
109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77206405 |
110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75222663 |
111 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73303190 |
112 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71231705 |
113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70875151 |
114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70381283 |
115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70215774 |
116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70115108 |
117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69566275 |
118 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68832425 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68125645 |
120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.68078204 |
121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.66054820 |
122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.65633628 |
123 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.65080718 |
124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65032828 |
125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.64057171 |
126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63456770 |
127 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.63289489 |
128 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.62345168 |
129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61706777 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60849045 |
131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59826711 |
132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.59762513 |
133 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.58799503 |
134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.58382743 |
135 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.57906722 |
136 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.56828620 |
137 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56137380 |
138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.54875159 |
139 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.54544104 |
140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.54119692 |
141 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.53848875 |
142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53537203 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 6.13797975 |
2 | MP0005666_abnormal_adipose_tissue | 4.14342109 |
3 | MP0002139_abnormal_hepatobiliary_system | 4.03129456 |
4 | MP0004130_abnormal_muscle_cell | 3.98748200 |
5 | MP0005360_urolithiasis | 3.50509421 |
6 | MP0010329_abnormal_lipoprotein_level | 3.45018011 |
7 | MP0005365_abnormal_bile_salt | 3.34113802 |
8 | MP0004185_abnormal_adipocyte_glucose | 3.32663860 |
9 | MP0008438_abnormal_cutaneous_collagen | 3.01335978 |
10 | MP0005375_adipose_tissue_phenotype | 2.92124544 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.87310830 |
12 | MP0002971_abnormal_brown_adipose | 2.86481650 |
13 | MP0002837_dystrophic_cardiac_calcinosis | 2.85480209 |
14 | MP0005085_abnormal_gallbladder_physiolo | 2.67901052 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55316669 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.39029861 |
17 | MP0003950_abnormal_plasma_membrane | 2.27140810 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.18361427 |
19 | MP0002877_abnormal_melanocyte_morpholog | 2.12083438 |
20 | MP0005451_abnormal_body_composition | 2.04657183 |
21 | MP0009115_abnormal_fat_cell | 2.03617296 |
22 | MP0000013_abnormal_adipose_tissue | 2.03572917 |
23 | MP0000609_abnormal_liver_physiology | 1.92259447 |
24 | MP0005332_abnormal_amino_acid | 1.90211948 |
25 | MP0000003_abnormal_adipose_tissue | 1.90074448 |
26 | MP0005334_abnormal_fat_pad | 1.89656949 |
27 | MP0003303_peritoneal_inflammation | 1.87862882 |
28 | MP0005257_abnormal_intraocular_pressure | 1.86623251 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.83129814 |
30 | MP0009840_abnormal_foam_cell | 1.81144949 |
31 | MP0000858_altered_metastatic_potential | 1.76822091 |
32 | MP0005535_abnormal_body_temperature | 1.75336946 |
33 | MP0003186_abnormal_redox_activity | 1.73736022 |
34 | MP0005275_abnormal_skin_tensile | 1.73524124 |
35 | MP0009785_altered_susceptibility_to | 1.68851750 |
36 | MP0002970_abnormal_white_adipose | 1.68298005 |
37 | MP0003075_altered_response_to | 1.62011930 |
38 | MP0003436_decreased_susceptibility_to | 1.61983692 |
39 | MP0002876_abnormal_thyroid_physiology | 1.57969221 |
40 | MP0005319_abnormal_enzyme/_coenzyme | 1.56408095 |
41 | MP0003806_abnormal_nucleotide_metabolis | 1.54420775 |
42 | MP0004510_myositis | 1.54350669 |
43 | MP0003252_abnormal_bile_duct | 1.52736377 |
44 | MP0003646_muscle_fatigue | 1.52299504 |
45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52279499 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.52163981 |
47 | MP0003453_abnormal_keratinocyte_physiol | 1.50849480 |
48 | MP0003724_increased_susceptibility_to | 1.45671240 |
49 | MP0001661_extended_life_span | 1.43955333 |
50 | MP0000685_abnormal_immune_system | 1.33249440 |
51 | MP0003172_abnormal_lysosome_physiology | 1.32207787 |
52 | MP0006082_CNS_inflammation | 1.30930881 |
53 | MP0002078_abnormal_glucose_homeostasis | 1.30736407 |
54 | MP0005448_abnormal_energy_balance | 1.29817066 |
55 | MP0009333_abnormal_splenocyte_physiolog | 1.28650938 |
56 | MP0005023_abnormal_wound_healing | 1.27061370 |
57 | MP0009643_abnormal_urine_homeostasis | 1.25902557 |
58 | MP0005165_increased_susceptibility_to | 1.25435584 |
59 | MP0003959_abnormal_lean_body | 1.25307245 |
60 | MP0003690_abnormal_glial_cell | 1.22198128 |
61 | MP0002909_abnormal_adrenal_gland | 1.20459998 |
62 | MP0004272_abnormal_basement_membrane | 1.20132260 |
63 | MP0000343_altered_response_to | 1.17275499 |
64 | MP0003091_abnormal_cell_migration | 1.16295271 |
65 | MP0005167_abnormal_blood-brain_barrier | 1.15772255 |
66 | MP0003448_altered_tumor_morphology | 1.15294811 |
67 | MP0006054_spinal_hemorrhage | 1.15087572 |
68 | MP0004019_abnormal_vitamin_homeostasis | 1.14898530 |
69 | MP0009764_decreased_sensitivity_to | 1.14377904 |
70 | MP0008775_abnormal_heart_ventricle | 1.13397036 |
71 | MP0005330_cardiomyopathy | 1.12592925 |
72 | MP0001790_abnormal_immune_system | 1.12574798 |
73 | MP0005387_immune_system_phenotype | 1.12574798 |
74 | MP0001666_abnormal_nutrient_absorption | 1.11630954 |
75 | MP0006138_congestive_heart_failure | 1.11216424 |
76 | MP0002419_abnormal_innate_immunity | 1.10598990 |
77 | MP0003195_calcinosis | 1.09976602 |
78 | MP0000751_myopathy | 1.09634306 |
79 | MP0003300_gastrointestinal_ulcer | 1.09596853 |
80 | MP0001764_abnormal_homeostasis | 1.08505890 |
81 | MP0001756_abnormal_urination | 1.06485383 |
82 | MP0005076_abnormal_cell_differentiation | 1.04890322 |
83 | MP0005058_abnormal_lysosome_morphology | 1.03049807 |
84 | MP0005000_abnormal_immune_tolerance | 1.02426368 |
85 | MP0003868_abnormal_feces_composition | 1.01765577 |
86 | MP0002998_abnormal_bone_remodeling | 1.01578712 |
87 | MP0005083_abnormal_biliary_tract | 1.01400639 |
88 | MP0000750_abnormal_muscle_regeneration | 1.01224263 |
89 | MP0004087_abnormal_muscle_fiber | 1.00676601 |
90 | MP0005025_abnormal_response_to | 0.99988214 |
91 | MP0001542_abnormal_bone_strength | 0.98155926 |
92 | MP0005385_cardiovascular_system_phenoty | 0.97402051 |
93 | MP0001544_abnormal_cardiovascular_syste | 0.97402051 |
94 | MP0005452_abnormal_adipose_tissue | 0.95349086 |
95 | MP0001845_abnormal_inflammatory_respons | 0.95146465 |
96 | MP0002254_reproductive_system_inflammat | 0.95051394 |
97 | MP0004233_abnormal_muscle_weight | 0.94512868 |
98 | MP0002332_abnormal_exercise_endurance | 0.89479010 |
99 | MP0000767_abnormal_smooth_muscle | 0.88230211 |
100 | MP0005595_abnormal_vascular_smooth | 0.87012984 |
101 | MP0004947_skin_inflammation | 0.86598790 |
102 | MP0009763_increased_sensitivity_to | 0.86419252 |
103 | MP0001727_abnormal_embryo_implantation | 0.84975131 |
104 | MP0002933_joint_inflammation | 0.84839998 |
105 | MP0003011_delayed_dark_adaptation | 0.84486102 |
106 | MP0000598_abnormal_liver_morphology | 0.83801949 |
107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82471134 |
108 | MP0000230_abnormal_systemic_arterial | 0.81947710 |
109 | MP0005671_abnormal_response_to | 0.81211254 |
110 | MP0000604_amyloidosis | 0.80536099 |
111 | MP0003329_amyloid_beta_deposits | 0.80490093 |
112 | MP0005620_abnormal_muscle_contractility | 0.79832796 |
113 | MP0003566_abnormal_cell_adhesion | 0.79582031 |
114 | MP0005164_abnormal_response_to | 0.78933988 |
115 | MP0004858_abnormal_nervous_system | 0.78366082 |
116 | MP0002452_abnormal_antigen_presenting | 0.76581187 |
117 | MP0002060_abnormal_skin_morphology | 0.74575381 |
118 | MP0003953_abnormal_hormone_level | 0.73772771 |
119 | MP0001881_abnormal_mammary_gland | 0.73629430 |
120 | MP0004036_abnormal_muscle_relaxation | 0.72857238 |
121 | MP0010630_abnormal_cardiac_muscle | 0.71912950 |
122 | MP0002972_abnormal_cardiac_muscle | 0.71708948 |
123 | MP0004215_abnormal_myocardial_fiber | 0.71433565 |
124 | MP0002822_catalepsy | 0.70905429 |
125 | MP0000249_abnormal_blood_vessel | 0.70414088 |
126 | MP0004084_abnormal_cardiac_muscle | 0.70208936 |
127 | MP0001879_abnormal_lymphatic_vessel | 0.69250970 |
128 | MP0003828_pulmonary_edema | 0.69016016 |
129 | MP0009642_abnormal_blood_homeostasis | 0.68858676 |
130 | MP0008961_abnormal_basal_metabolism | 0.67433400 |
131 | MP0003279_aneurysm | 0.66276637 |
132 | MP0008469_abnormal_protein_level | 0.65917216 |
133 | MP0001853_heart_inflammation | 0.64350021 |
134 | MP0000759_abnormal_skeletal_muscle | 0.63711753 |
135 | MP0005376_homeostasis/metabolism_phenot | 0.62477166 |
136 | MP0010368_abnormal_lymphatic_system | 0.61326089 |
137 | MP0002168_other_aberrant_phenotype | 0.61188622 |
138 | MP0002295_abnormal_pulmonary_circulatio | 0.60106306 |
139 | MP0001533_abnormal_skeleton_physiology | 0.60094804 |
140 | MP0000749_muscle_degeneration | 0.59296746 |
141 | MP0002269_muscular_atrophy | 0.59024958 |
142 | MP0005647_abnormal_sex_gland | 0.58342440 |
143 | MP0005266_abnormal_metabolism | 0.57721119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.89315594 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.89315594 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.89315594 |
4 | Hyperglycinuria (HP:0003108) | 5.60817986 |
5 | Hypoglycemic coma (HP:0001325) | 4.98603578 |
6 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.78511882 |
7 | Abnormality of glycine metabolism (HP:0010895) | 4.74274056 |
8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.74274056 |
9 | Vertebral compression fractures (HP:0002953) | 4.68365903 |
10 | Oligomenorrhea (HP:0000876) | 4.63536840 |
11 | Myoglobinuria (HP:0002913) | 4.35636117 |
12 | Complement deficiency (HP:0004431) | 4.29686702 |
13 | Hyperammonemia (HP:0001987) | 4.22631690 |
14 | Xanthomatosis (HP:0000991) | 4.19018243 |
15 | Ketosis (HP:0001946) | 4.17740740 |
16 | Dicarboxylic aciduria (HP:0003215) | 4.10103150 |
17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.10103150 |
18 | Hypertriglyceridemia (HP:0002155) | 4.06340303 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.96237544 |
20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.92599941 |
21 | Acanthosis nigricans (HP:0000956) | 3.89914981 |
22 | Vacuolated lymphocytes (HP:0001922) | 3.89619215 |
23 | Hyperlipoproteinemia (HP:0010980) | 3.88028030 |
24 | Dysostosis multiplex (HP:0000943) | 3.82823242 |
25 | Rhabdomyolysis (HP:0003201) | 3.82765590 |
26 | Ketoacidosis (HP:0001993) | 3.78799322 |
27 | Hyperglycinemia (HP:0002154) | 3.61096324 |
28 | Deep venous thrombosis (HP:0002625) | 3.50879686 |
29 | Increased muscle lipid content (HP:0009058) | 3.40399425 |
30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.37581705 |
31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.37581705 |
32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.37581705 |
33 | Epidermoid cyst (HP:0200040) | 3.37127452 |
34 | Hydroxyprolinuria (HP:0003080) | 3.35286334 |
35 | Abnormality of proline metabolism (HP:0010907) | 3.35286334 |
36 | Nuclear cataract (HP:0100018) | 3.32857340 |
37 | Abnormality of complement system (HP:0005339) | 3.27088645 |
38 | Axonal loss (HP:0003447) | 3.26836191 |
39 | Mucopolysacchariduria (HP:0008155) | 3.23446582 |
40 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.23446582 |
41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.20772771 |
42 | Premature rupture of membranes (HP:0001788) | 3.16286011 |
43 | Protrusio acetabuli (HP:0003179) | 3.11761047 |
44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10255168 |
45 | Hypolipoproteinemia (HP:0010981) | 3.05073002 |
46 | Generalized aminoaciduria (HP:0002909) | 3.01753011 |
47 | Nausea (HP:0002018) | 2.98805188 |
48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98336191 |
49 | Myocardial infarction (HP:0001658) | 2.95828912 |
50 | Hepatic necrosis (HP:0002605) | 2.86565124 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.78472189 |
52 | Difficulty running (HP:0009046) | 2.77858459 |
53 | Glomerulonephritis (HP:0000099) | 2.76651771 |
54 | Hypercholesterolemia (HP:0003124) | 2.76374846 |
55 | Increased cerebral lipofuscin (HP:0011813) | 2.75844738 |
56 | Increased connective tissue (HP:0009025) | 2.74446524 |
57 | Loss of speech (HP:0002371) | 2.73826657 |
58 | Intrahepatic cholestasis (HP:0001406) | 2.72830908 |
59 | Skin nodule (HP:0200036) | 2.71376916 |
60 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.64300170 |
61 | Prolonged neonatal jaundice (HP:0006579) | 2.63229678 |
62 | Cervical subluxation (HP:0003308) | 2.62798555 |
63 | Cerebral edema (HP:0002181) | 2.62214733 |
64 | Lethargy (HP:0001254) | 2.60923945 |
65 | Abnormal cartilage morphology (HP:0002763) | 2.57017535 |
66 | Bone cyst (HP:0012062) | 2.54137766 |
67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.50872858 |
68 | Hemorrhage of the eye (HP:0011885) | 2.50789740 |
69 | Insulin resistance (HP:0000855) | 2.47522904 |
70 | Abnormality of serum amino acid levels (HP:0003112) | 2.44060217 |
71 | Vomiting (HP:0002013) | 2.43203843 |
72 | Metabolic acidosis (HP:0001942) | 2.40235973 |
73 | Mesangial abnormality (HP:0001966) | 2.38220762 |
74 | Prolonged partial thromboplastin time (HP:0003645) | 2.37280866 |
75 | Pancreatitis (HP:0001733) | 2.36866869 |
76 | Long foot (HP:0001833) | 2.29494057 |
77 | Mitral stenosis (HP:0001718) | 2.28730186 |
78 | Abnormality of purine metabolism (HP:0004352) | 2.28566945 |
79 | Conjunctival hamartoma (HP:0100780) | 2.27702155 |
80 | Achilles tendon contracture (HP:0001771) | 2.27441063 |
81 | Abnormality of the Achilles tendon (HP:0005109) | 2.25294530 |
82 | Exercise-induced myalgia (HP:0003738) | 2.24401800 |
83 | Pigmentary retinal degeneration (HP:0001146) | 2.22902015 |
84 | Multiple enchondromatosis (HP:0005701) | 2.19276360 |
85 | Proximal tubulopathy (HP:0000114) | 2.18249685 |
86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17361301 |
87 | Cholecystitis (HP:0001082) | 2.15377576 |
88 | Abnormal gallbladder physiology (HP:0012438) | 2.15377576 |
89 | Hypobetalipoproteinemia (HP:0003563) | 2.14994592 |
90 | Muscle stiffness (HP:0003552) | 2.14614177 |
91 | Purpura (HP:0000979) | 2.14540357 |
92 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13262880 |
93 | Joint hemorrhage (HP:0005261) | 2.12221686 |
94 | Vascular calcification (HP:0004934) | 2.11610236 |
95 | Right ventricular cardiomyopathy (HP:0011663) | 2.11299342 |
96 | Tetraparesis (HP:0002273) | 2.11153430 |
97 | Facial diplegia (HP:0001349) | 2.11027034 |
98 | Hypoglycemic seizures (HP:0002173) | 2.10473133 |
99 | Progressive neurologic deterioration (HP:0002344) | 2.10297804 |
100 | Renal cortical cysts (HP:0000803) | 2.10191129 |
101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08154536 |
102 | Short nail (HP:0001799) | 2.08151333 |
103 | Hyperglycemia (HP:0003074) | 2.07269719 |
104 | Ovoid vertebral bodies (HP:0003300) | 2.06991008 |
105 | Hypokinesia (HP:0002375) | 2.06558873 |
106 | Palpitations (HP:0001962) | 2.05194696 |
107 | Nonimmune hydrops fetalis (HP:0001790) | 2.04651065 |
108 | Methylmalonic aciduria (HP:0012120) | 2.04484215 |
109 | Ragged-red muscle fibers (HP:0003200) | 2.04298943 |
110 | Mutism (HP:0002300) | 2.03968975 |
111 | Gastrointestinal stroma tumor (HP:0100723) | 2.03283326 |
112 | Cardiovascular calcification (HP:0011915) | 2.02624719 |
113 | Growth hormone excess (HP:0000845) | 2.02052953 |
114 | Acute encephalopathy (HP:0006846) | 1.99010332 |
115 | Increased serum pyruvate (HP:0003542) | 1.98995438 |
116 | Abnormality of glycolysis (HP:0004366) | 1.98995438 |
117 | Lipoatrophy (HP:0100578) | 1.97846038 |
118 | Opisthotonus (HP:0002179) | 1.97483467 |
119 | Neurofibrillary tangles (HP:0002185) | 1.95185321 |
120 | Abnormality of macrophages (HP:0004311) | 1.94315158 |
121 | Prenatal maternal abnormality (HP:0002686) | 1.93146535 |
122 | Ileus (HP:0002595) | 1.92640011 |
123 | Beaking of vertebral bodies (HP:0004568) | 1.91989008 |
124 | Osteolytic defects of the hand bones (HP:0009699) | 1.91148376 |
125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91148376 |
126 | Hyporeflexia of lower limbs (HP:0002600) | 1.90394261 |
127 | Nephritis (HP:0000123) | 1.89283165 |
128 | Broad metatarsal (HP:0001783) | 1.88644677 |
129 | Abnormality of carpal bone ossification (HP:0006257) | 1.87030505 |
130 | Hepatosplenomegaly (HP:0001433) | 1.86049954 |
131 | Upper motor neuron abnormality (HP:0002127) | 1.86002898 |
132 | Cardiomegaly (HP:0001640) | 1.84828277 |
133 | Muscle fiber splitting (HP:0003555) | 1.84681684 |
134 | Multiple lipomas (HP:0001012) | 1.84646243 |
135 | Hypertensive crisis (HP:0100735) | 1.84143165 |
136 | Bone pain (HP:0002653) | 1.84105345 |
137 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83442977 |
138 | Type 1 muscle fiber predominance (HP:0003803) | 1.83132750 |
139 | Tachypnea (HP:0002789) | 1.82972812 |
140 | Amyloidosis (HP:0011034) | 1.82394552 |
141 | Distal lower limb amyotrophy (HP:0008944) | 1.82014652 |
142 | Sensorimotor neuropathy (HP:0007141) | 1.81698719 |
143 | Neonatal onset (HP:0003623) | 1.80972652 |
144 | Spinal rigidity (HP:0003306) | 1.80771133 |
145 | Cerebral inclusion bodies (HP:0100314) | 1.80557776 |
146 | Esophageal varix (HP:0002040) | 1.79767368 |
147 | Esophageal neoplasm (HP:0100751) | 1.79446364 |
148 | Neoplasm of head and neck (HP:0012288) | 1.79446364 |
149 | Increased serum ferritin (HP:0003281) | 1.79279555 |
150 | Lactic acidosis (HP:0003128) | 1.77350865 |
151 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76308792 |
152 | Rough bone trabeculation (HP:0100670) | 1.75693613 |
153 | Cerebral hemorrhage (HP:0001342) | 1.73523926 |
154 | Pathologic fracture (HP:0002756) | 1.73072905 |
155 | Hepatocellular necrosis (HP:0001404) | 1.72713234 |
156 | Asymmetric septal hypertrophy (HP:0001670) | 1.71723634 |
157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.71671135 |
158 | Cerebral aneurysm (HP:0004944) | 1.71297557 |
159 | Retinal atrophy (HP:0001105) | 1.71201778 |
160 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.71195472 |
161 | Apathy (HP:0000741) | 1.71128218 |
162 | Abnormal trabecular bone morphology (HP:0100671) | 1.70697699 |
163 | Distal lower limb muscle weakness (HP:0009053) | 1.70224443 |
164 | Elbow flexion contracture (HP:0002987) | 1.69917520 |
165 | Ankle contracture (HP:0006466) | 1.69262541 |
166 | J-shaped sella turcica (HP:0002680) | 1.68916737 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.35453537 |
2 | BCKDK | 5.26257068 |
3 | CAMK1D | 4.38705609 |
4 | MST1R | 3.52788534 |
5 | SIK1 | 3.37850994 |
6 | CAMK1G | 3.37292129 |
7 | PDK4 | 3.19782876 |
8 | PDK3 | 3.19782876 |
9 | ERN1 | 2.86703020 |
10 | EPHA2 | 2.69926032 |
11 | TESK1 | 2.53044034 |
12 | PKN2 | 2.36255376 |
13 | PDK2 | 2.27302004 |
14 | RIPK1 | 2.27193516 |
15 | TTN | 2.21490888 |
16 | PAK4 | 2.12558977 |
17 | PIM2 | 2.08820316 |
18 | TAOK2 | 2.01508206 |
19 | PIK3CA | 1.93849292 |
20 | MYLK | 1.74583501 |
21 | FGFR4 | 1.72171974 |
22 | LMTK2 | 1.71589599 |
23 | MAP3K14 | 1.64812974 |
24 | INSRR | 1.64189824 |
25 | PRKAA2 | 1.57249911 |
26 | MET | 1.47331663 |
27 | ARAF | 1.42616522 |
28 | CDC42BPA | 1.35099986 |
29 | GRK7 | 1.29464906 |
30 | PRPF4B | 1.29276120 |
31 | MAPKAPK3 | 1.27893413 |
32 | EPHB2 | 1.25562411 |
33 | NEK9 | 1.20982256 |
34 | TGFBR2 | 1.20138169 |
35 | SMG1 | 1.19017974 |
36 | TIE1 | 1.18435250 |
37 | IKBKB | 1.12574915 |
38 | CDK9 | 1.12120363 |
39 | LIMK1 | 1.10022585 |
40 | MAP2K1 | 1.05485258 |
41 | PDGFRA | 1.05036498 |
42 | MOS | 1.00697541 |
43 | PTK6 | 0.96384496 |
44 | FLT3 | 0.93558218 |
45 | FGFR3 | 0.93225207 |
46 | TESK2 | 0.92822465 |
47 | MAP2K3 | 0.92635274 |
48 | PDPK1 | 0.91647361 |
49 | ACVR1B | 0.90893828 |
50 | NEK1 | 0.90857957 |
51 | JAK1 | 0.88396691 |
52 | EPHB1 | 0.86900477 |
53 | CDK6 | 0.86494699 |
54 | PHKG2 | 0.85309799 |
55 | PHKG1 | 0.85309799 |
56 | PIK3CG | 0.84795520 |
57 | TBK1 | 0.82474838 |
58 | PBK | 0.80708664 |
59 | CLK1 | 0.80693920 |
60 | CHUK | 0.79859149 |
61 | MATK | 0.79520844 |
62 | ABL2 | 0.79096273 |
63 | BUB1 | 0.77800253 |
64 | FGFR2 | 0.76396601 |
65 | TYK2 | 0.75177008 |
66 | PRKAA1 | 0.74858444 |
67 | MAP3K1 | 0.74458244 |
68 | FRK | 0.73606165 |
69 | TAOK1 | 0.73215878 |
70 | GSK3A | 0.72012911 |
71 | MAP3K3 | 0.70617284 |
72 | JAK2 | 0.69965375 |
73 | IRAK4 | 0.69946744 |
74 | MAP2K4 | 0.66655499 |
75 | PRKACG | 0.64546510 |
76 | ICK | 0.64401440 |
77 | MAPK11 | 0.63587006 |
78 | KDR | 0.62916734 |
79 | PDK1 | 0.62667217 |
80 | OBSCN | 0.62614169 |
81 | SIK3 | 0.62562633 |
82 | MTOR | 0.61298953 |
83 | IRAK3 | 0.61152386 |
84 | ILK | 0.59066837 |
85 | LRRK2 | 0.58861808 |
86 | MAP3K8 | 0.58798205 |
87 | CSK | 0.57771122 |
88 | PTK2B | 0.56799428 |
89 | STK10 | 0.56420104 |
90 | PRKD1 | 0.55835894 |
91 | MAPK12 | 0.55810321 |
92 | BMX | 0.55555034 |
93 | STK16 | 0.55473109 |
94 | MAP3K12 | 0.55098110 |
95 | PAK2 | 0.52949391 |
96 | PRKCH | 0.52839492 |
97 | IGF1R | 0.52765613 |
98 | PRKG2 | 0.52638189 |
99 | DDR2 | 0.51260233 |
100 | TLK1 | 0.50905536 |
101 | EIF2AK1 | 0.50850484 |
102 | MAPK4 | 0.49472932 |
103 | TAOK3 | 0.49251749 |
104 | RET | 0.48186285 |
105 | IRAK2 | 0.48135597 |
106 | NME1 | 0.46434623 |
107 | MAP2K6 | 0.45916095 |
108 | DAPK3 | 0.45088814 |
109 | LATS1 | 0.44826916 |
110 | MUSK | 0.44775144 |
111 | PAK1 | 0.43665254 |
112 | PINK1 | 0.43479937 |
113 | EEF2K | 0.43321753 |
114 | DAPK2 | 0.43314382 |
115 | MAP3K11 | 0.43076673 |
116 | PRKCI | 0.42620083 |
117 | BLK | 0.42028495 |
118 | MAP2K2 | 0.40482524 |
119 | IKBKE | 0.39587598 |
120 | FER | 0.38185146 |
121 | MAP3K6 | 0.36878244 |
122 | ERBB4 | 0.36453542 |
123 | MAPKAPK2 | 0.36321388 |
124 | AKT2 | 0.36155513 |
125 | ADRBK2 | 0.33788333 |
126 | PDGFRB | 0.33538333 |
127 | MAP3K13 | 0.33131589 |
128 | BRAF | 0.32995959 |
129 | JAK3 | 0.32760369 |
130 | PAK3 | 0.32298486 |
131 | CDK8 | 0.31266500 |
132 | TRPM7 | 0.30044710 |
133 | FGFR1 | 0.29710346 |
134 | INSR | 0.28824504 |
135 | PTK2 | 0.27080639 |
136 | SRC | 0.26043677 |
137 | CAMK1 | 0.25703038 |
138 | CDK4 | 0.24727041 |
139 | DMPK | 0.23596526 |
140 | KIT | 0.23156519 |
141 | CAMK2G | 0.23140303 |
142 | NME2 | 0.22434246 |
143 | RPS6KL1 | 0.22175985 |
144 | RPS6KC1 | 0.22175985 |
145 | LATS2 | 0.21662290 |
146 | PRKCZ | 0.21626463 |
147 | PRKD3 | 0.21327055 |
148 | ABL1 | 0.21120362 |
149 | KSR2 | 0.20200354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.99129679 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.95968902 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.61009049 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.55375145 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.54230457 |
6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.44156013 |
7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.30210131 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90551416 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61680917 |
10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.53065127 |
11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36012121 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27461996 |
13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.27299055 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13998530 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04575478 |
16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01008397 |
17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.00981640 |
18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.91467247 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90339384 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.87929850 |
21 | Proteasome_Homo sapiens_hsa03050 | 1.84418014 |
22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83079249 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79899913 |
24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.78171530 |
25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.76044862 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67161632 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64707561 |
28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62535926 |
29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55451838 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52647687 |
31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50688118 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49809281 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48893939 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41184776 |
35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39561197 |
36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36717010 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34463949 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32698841 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29782733 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29031166 |
41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28693094 |
42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27151224 |
43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25450420 |
44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18679983 |
45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15233027 |
46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15012642 |
47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14958000 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14937013 |
49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10285047 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10227396 |
51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06692976 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01991809 |
53 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01847675 |
54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99840241 |
55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98766444 |
56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98718983 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98175106 |
58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97221949 |
59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96227071 |
60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94850394 |
61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90338610 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.87104743 |
63 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86567193 |
64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85715961 |
65 | Bladder cancer_Homo sapiens_hsa05219 | 0.85205496 |
66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84577113 |
67 | ABC transporters_Homo sapiens_hsa02010 | 0.83691214 |
68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83120350 |
69 | Mineral absorption_Homo sapiens_hsa04978 | 0.81662355 |
70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81404265 |
71 | Bile secretion_Homo sapiens_hsa04976 | 0.81113035 |
72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80813502 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.80044880 |
74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78880518 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77243249 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76950628 |
77 | Lysine degradation_Homo sapiens_hsa00310 | 0.75871288 |
78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73744795 |
79 | Allograft rejection_Homo sapiens_hsa05330 | 0.72358709 |
80 | Asthma_Homo sapiens_hsa05310 | 0.70865261 |
81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70470477 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69265174 |
83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67380745 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66960860 |
85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64540364 |
86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63507291 |
87 | Hepatitis C_Homo sapiens_hsa05160 | 0.63108487 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.61788923 |
89 | Shigellosis_Homo sapiens_hsa05131 | 0.61448504 |
90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60177892 |
91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58745082 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.58616959 |
93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58119464 |
94 | Phagosome_Homo sapiens_hsa04145 | 0.53940499 |
95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51362547 |
96 | Legionellosis_Homo sapiens_hsa05134 | 0.50805890 |
97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50375145 |
98 | Influenza A_Homo sapiens_hsa05164 | 0.50316832 |
99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49681428 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49609028 |
101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48334709 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48231338 |
103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47598375 |
104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47168025 |
105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42973984 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42033756 |
107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41316037 |
108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39395027 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39308561 |
110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38421914 |
111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36959417 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35181913 |
113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34552549 |
114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34512115 |
115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33834894 |
116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29891851 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28620418 |
118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27526531 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25715213 |
120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23729612 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23139746 |
122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22085279 |
123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20342218 |
124 | Lysosome_Homo sapiens_hsa04142 | 0.19654984 |
125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18599860 |
126 | Prion diseases_Homo sapiens_hsa05020 | 0.14722734 |
127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.14306637 |
128 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.10502653 |
129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10271831 |
130 | Amoebiasis_Homo sapiens_hsa05146 | 0.09400295 |
131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09251429 |
132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08339433 |
133 | Focal adhesion_Homo sapiens_hsa04510 | 0.05245050 |
134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.03790882 |
135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03210133 |
136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.00781599 |
137 | Renin secretion_Homo sapiens_hsa04924 | -0.0315905 |
138 | Pertussis_Homo sapiens_hsa05133 | -0.0271811 |
139 | Malaria_Homo sapiens_hsa05144 | -0.0226275 |
140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0210141 |